etidronate has been researched along with Spinal Diseases in 7 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
| " The time course of changes in PTH levels following cessation of dosing was unaffected by calcium supplementation." | 2.70 | Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis. ( Collette, J; Eastell, R; Ethgen, D; Reginster, JY; Roumagnac, I; Russell, RG; Zegels, B, 2001) |
| "We conclude that treatment of postmenopausal osteoporosis with oestrogen/progestogen for 3 years results in net spinal bone gain and a positive effect on calcium balance slightly better than that of intermittent etidronate." | 2.67 | A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis. ( Charles, P; Hasling, C; Jensen, FT; Mosekilde, L, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasling, C | 1 |
| Charles, P | 1 |
| Jensen, FT | 1 |
| Mosekilde, L | 1 |
| MacGowan, JR | 1 |
| Pringle, J | 1 |
| Morris, VH | 1 |
| Stamp, TC | 1 |
| Zegels, B | 1 |
| Eastell, R | 1 |
| Russell, RG | 1 |
| Ethgen, D | 1 |
| Roumagnac, I | 1 |
| Collette, J | 1 |
| Reginster, JY | 1 |
| Sahota, O | 1 |
| Fowler, I | 1 |
| Blackwell, PJ | 1 |
| Lawson, N | 1 |
| Cawte, SA | 1 |
| San, P | 1 |
| Masud, T | 1 |
| Hosking, DJ | 1 |
| Oppenheim, BE | 1 |
| Cantez, S | 1 |
| Tanno, T | 1 |
| Moser, E | 1 |
3 trials available for etidronate and Spinal Diseases
| Article | Year |
|---|---|
A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.
Topics: Administration, Oral; Aged; Bone Density; Calcium; Drug Administration Schedule; Drug Therapy, Combi | 1994 |
Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis.
Topics: Aged; Calcium Channel Blockers; Collagen; Cross-Linking Reagents; Double-Blind Method; Etidronic Aci | 2001 |
A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodelin | 2000 |
4 other studies available for etidronate and Spinal Diseases
| Article | Year |
|---|---|
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |
What causes lower neck uptake in bone scans?
Topics: Adult; Cervical Vertebrae; Diphosphates; Etidronic Acid; Humans; Laryngeal Cartilages; Neoplasm Meta | 1977 |
[Experimental study on the spinal lesions in hyperostotic mouse (twy/twy): special reference to the pathogenesis of the ossification of the spinal ligaments and to the action of ethane-1-hydroxy-1, 1-diphosphonate (EHDP)].
Topics: Animals; Etidronic Acid; Hyperostosis; Ligaments; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Ossi | 1992 |
[Skeletal scintigraphic findings in spinal diseases].
Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Humans; Organometallic Compounds; Organotechnetium C | 1989 |